These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects. Cho HY; Yoo HD; Lee YB Neuroscience; 2010 Aug; 169(1):378-87. PubMed ID: 20438811 [TBL] [Abstract][Full Text] [Related]
3. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531 [TBL] [Abstract][Full Text] [Related]
5. Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography. Wanek T; Römermann K; Mairinger S; Stanek J; Sauberer M; Filip T; Traxl A; Kuntner C; Pahnke J; Bauer F; Erker T; Löscher W; Müller M; Langer O Mol Pharm; 2015 Sep; 12(9):3214-25. PubMed ID: 26202880 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Uhr M; Tontsch A; Namendorf C; Ripke S; Lucae S; Ising M; Dose T; Ebinger M; Rosenhagen M; Kohli M; Kloiber S; Salyakina D; Bettecken T; Specht M; Pütz B; Binder EB; Müller-Myhsok B; Holsboer F Neuron; 2008 Jan; 57(2):203-9. PubMed ID: 18215618 [TBL] [Abstract][Full Text] [Related]
7. Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation. Corponi F; Fabbri C; Boriani G; Diemberger I; Albani D; Forloni G; Serretti A Neuropsychobiology; 2019; 77(2):67-72. PubMed ID: 30544110 [TBL] [Abstract][Full Text] [Related]
8. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier. Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927 [TBL] [Abstract][Full Text] [Related]
9. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. Cho JH; Yoon YD; Park JY; Song EJ; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591 [TBL] [Abstract][Full Text] [Related]
10. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685 [TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel. Noonan AM; Eisch RA; Liewehr DJ; Sissung TM; Venzon DJ; Flagg TP; Haigney MC; Steinberg SM; Figg WD; Piekarz RL; Bates SE Clin Cancer Res; 2013 Jun; 19(11):3095-104. PubMed ID: 23589175 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo. Hill CR; Jamieson D; Thomas HD; Brown CD; Boddy AV; Veal GJ Biochem Pharmacol; 2013 Jan; 85(1):29-37. PubMed ID: 23063411 [TBL] [Abstract][Full Text] [Related]
13. Gao YL; He B DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659 [TBL] [Abstract][Full Text] [Related]
15. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. Mizuno T; Fukudo M; Terada T; Kamba T; Nakamura E; Ogawa O; Inui K; Katsura T Drug Metab Pharmacokinet; 2012; 27(6):631-9. PubMed ID: 22673043 [TBL] [Abstract][Full Text] [Related]
16. ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients. García M; Macías RM; Cubero JJ; Benítez J; Caravaca F; Gervasini G Eur J Clin Pharmacol; 2013 Mar; 69(3):385-93. PubMed ID: 22886152 [TBL] [Abstract][Full Text] [Related]
17. Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients. Maleki M; Sayyah M; Kamgarpour F; Karimipoor M; Arab A; Rajabi A; Gharagozli K; Shamshiri AR; Shahsavand Ananloo E Iran Biomed J; 2010 Jul; 14(3):89-96. PubMed ID: 21079659 [TBL] [Abstract][Full Text] [Related]
18. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients. Kurzawski M; Bartnicka L; Florczak M; Górnik W; Droździk M Pharmacol Rep; 2007; 59(1):107-11. PubMed ID: 17377214 [TBL] [Abstract][Full Text] [Related]
19. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. Tang SC; Lagas JS; Lankheet NA; Poller B; Hillebrand MJ; Rosing H; Beijnen JH; Schinkel AH Int J Cancer; 2012 Jan; 130(1):223-33. PubMed ID: 21351087 [TBL] [Abstract][Full Text] [Related]
20. Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study. Johnson DH; Sutherland D; Acosta EP; Erdem H; Richardson D; Haas DW PLoS One; 2013; 8(12):e82672. PubMed ID: 24349334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]